FDA NDC Directory · JSON-LD · Markdown

NAVITRUX

NDC 83831-153 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namefosaprepitant
Labeler / ManufacturerAVYXA Pharma, LLC
Marketing categoryNew Drug Application (innovator) · App NDA220436
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/5mL)
Marketing started20260723
Package count1

External sources

Source: openFDA. Public-domain (CC0).